[TARS] QoQ Quarter Result on 31-Dec-2023 [#Q4]

Stock
[TARS] Tarsus Pharmaceuticals, Inc.
Announcement Date
27-Feb-2024
Financial Year
2023
Quarter
31-Dec-2023 [#Q4]
Profit Trend
QoQ- -7.03%
YoY- -220.40%
Quarter Report
TARS's Result
TARS's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Revenue 48,118 40,813 27,614 13,076 1,871 15,277 2,500 614.34%
PBT -23,420 -33,290 -35,731 -41,902 -40,935 -31,424 -23,419 0.00%
Tax 0 0 -270 30,398 -1,787 -27,078 -1,533 -
NP -23,420 -33,290 -35,731 -41,902 -39,148 -31,424 -21,886 4.60%
Tax Rate - - - - - - - -
Total Cost 71,538 74,103 63,345 54,978 41,019 46,701 24,386 104.52%
Ratio Analysis
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
NP Margin -48.67 -81.57 -129.39 -320.45 -2,092.36 -205.69 -875.44 -85.35%
Per Share
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
EPS -0.61 -0.88 -1.01 -1.31 -1.28 -1.17 -0.82 -17.85%
EPS Diluted -0.61 -0.88 -1.01 -1.31 -1.28 -1.17 -0.82 -17.85%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.